Contraindicated (1)pentobarbital will lower the extent or impact of cariprazine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. CYP3A4 is responsible for the formation and elimination of cariprazine's active metabolites.pentobarbital will lessen the level or result of estropipate by affecting hepatic/intestinal enzyme CYP